Back

6p.R220L is a pathogenic novel GLA gene mutation responsible for a cardiac phenotype of Fabry disease

11 May 2024 (16:09 - 16:18)
Organised by: Logo
Congress Presentation Part of: Cardiomyopathies - imaging in the hypertrophied heart Clinical HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Ipek Aydin

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Turkiye)

3 More presentations in this session

Presentation thumbnail
Skeletal myopathy associated with hypertrophic cardiomyopathy – one or two diseases?
Professor R. Jurcut (Bucharest, RO)
Slides Video
Presentation thumbnail
The importance of multimodality imaging in the assessment and management of symptoms in hypertrophic cardiomyopathy
Doctor A. Pinho (Porto, PT)
Slides Video
Presentation thumbnail
Severe left ventricular hypertrophy and extensive fibrosis with concomitant arterial hypertension: a diagnostic dilemma.
Doctor E. Gnan (Milan, IT)
Slides Video

Access the full session

Session thumbnail
Cardiomyopathies - imaging in the hypertrophied heart

The Event

Event poster

Heart Failure 2024

11 May 2024 16:09 CET
You may be interested in
thumbnail
Congress Session
When one diagnosis is not enough: overlap cardiomyopathies and genetic clues
thumbnail
Congress Presentation
Hypertrophic cardiomyopathy in a Mexican female with Fabry disease: challenges in multidisciplinary diagnosis. family with novel pathogenic GLA gene variants.
thumbnail
Congress Presentation
A patient with multiple myeloma and an unexpected diagnosis: the role of cardiac MRI to unveil a hidden cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources